Crowdsourcing Consensus on the Utilisation of Antiplatelet Therapy in NSTE-ACS


Promoting and facilitating strategies to improve cardiovascular health worldwide

Tratamiento con ACOD en pacientes con FA post-ICP

ISCP On-Demand Webinar











ISCP Webinar: Cardiovascular Risk Management of Diabetes and SGLT2 Inhibitors

 

newsfeed

Strict phosphate control may slow coronary artery calcification for patients on dialysis

Posted on February 24, 2021

Compared with standard targets, lower serum phosphate levels led to smaller changes in coronary artery calcification scores, suggesting stricter phosphate control may... more

Treatment by physician of same sex may confer better CV outcomes

Posted on February 24, 2021

Female physicians demonstrated better patient outcomes compared with their male counterparts due to the lower likelihood of male physicians providing guideline-recommended care... more

CV involvement in malaria death may be area for diagnostic, therapeutic improvement

Posted on February 24, 2021

Due to potential underreporting of CV complications in malaria infection, consistent monitoring for and treatment of CV complications may represent unmet areas... more

High plant protein intake inversely associated with CVD, dementia mortality in older women

Posted on February 24, 2021

Dietary protein from different sources was associated with varying risk for CVD mortality and death from dementia or cancer among older women,... more

ISCP book series

Current Cardiovascular Therapy
Kaski, Juan Carlos.

Series Editor: Juan Carlos Kaski Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series created with the support of the International Society of Cardiovascular Pharmacotherapy (ISCP) is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action,...

  • Antiplatelet and Anticoagulation Therapy

    A. Ferro, D.A. Garcia (Eds.)

  • Pharmacological Treatment of Acute Coronary Syndromes

    Avanzas, Pablo; Clemmensen, Peter(Eds.)

  • Atrial Fibrillation Therapy

    Gheorghe-Andrei Dan, Antoni Bayes de Luna, John Camm(Eds.)

board of directors

Providing a leadership and advocacy role amongst members of their national societies.

 

  •  Jack Tan

    President

      Dr Jack Tan graduated from the Faculty of Medicine, National University of Singapore in 1997. In 2007, he spent one year at UC Davis (more…) more

  •  Thomas Kahan

    Vice President/Co Treasurer

    Affiliations/Memberships Professor of Medicine Department of Clinical Sciences, Danderyd Hospital Division of Cardiovascular Medicine (more…) more

  •  Pablo Avanzas

    Secretary

    Affiliations/Memberships Consultant in Invasive Cardiology, Hospital Universitario Central de Asturias, Oviedo, Spain Fellow of (more…) more

  • Doreen Tan

    Co Treasurer

     Doreen Su-Yin Tan is Associate Professor, Clinical & Pharmacy Practice, at the National University of Singapore. Affiliations (more…) more